Maternal-Fetal Medicine · Clinical Discussion
Mirror Syndrome
Ballantyne Syndrome: A Triad of Maternal, Fetal, and Placental Edema
Dr. C. Onyeije, MFM
First described 1892
Rare · Life-Threatening
Definition
What Is Mirror Syndrome?
🤰
Mother
Systemic edema, hemodilution, hypertension
🫀
Placenta
Massive placentomegaly with fluid collection
👶
Fetus
Hydrops fetalis — ≥2 body cavity effusions
Maternal fluid retention "mirrors" fetal hydrops — hence the name. First described by Ballantyne in 1892.
Pathophysiology
How It Develops
Severe
Fetal Hydrops
→
Placentomegaly
+ Edema
→
Anti-angiogenic
Factor Release
→
Endothelial
Dysfunction
→
Massive Maternal
Fluid Shifts
Placental hyperplacentosis drives elevated hCG and release of vasoactive mediators, producing systemic maternal edema.
Epidemiology
How Common?
~29%
of severe fetal hydrops pregnancies
22–28 wks
Mean gestational age at onset
67.2%
Fetal mortality rate
Rare
Exact incidence unknown
Etiology
Underlying Causes of Fetal Hydrops
Twin-Twin Transfusion Syndrome (TTTS)
18%
Structural Anomalies (Ebstein, SCT)
Other
Any cause of immune or non-immune hydrops may trigger Mirror syndrome.
Clinical Presentation
Maternal Signs & Symptoms
🤰
- 62.2% Maternal edema (face, limbs, generalized)
- 54.9% Hypoalbuminemia
- 39.0% Anemia — secondary to hemodilution
- 39.0% New-onset hypertension
- Elevated Serum hCG (hyperplacentosis)
- Variable Headache, visual disturbances, elevated LFTs
Fetal & Placental Findings
Fetal & Placental Findings
👶
Fetal Hydrops
≥2 body cavity effusions
Mean onset: 29 weeks (vs. 31 wks in non-mirror hydrops)
📊
Edema Severity
Fetal edema-to-BPD ratio:
0.23 (Mirror) vs. 0.16 (non-mirror)
🫁
Pleural / Ascites
Bilateral pleural effusions, ascites, skin edema, pericardial effusion
🟥
Placentomegaly
Massive placental edema with fluid collection — a hallmark finding
Differential Diagnosis
Mirror Syndrome vs. Severe Preeclampsia
| Parameter |
Mirror Syndrome |
Severe Preeclampsia |
| Hemodynamics |
Hemodilution ↓ Hct |
Hemoconcentration ↑ Hct |
| Oncotic Pressure |
Severe hypoalbuminemia |
Mild–moderate decrease |
| Fetal Status |
Always severe hydrops |
IUGR or normal |
| Placenta |
Placentomegaly + edema |
Infarctions / insufficiency |
| Uric Acid |
Normal–mildly elevated |
Severely elevated |
Diagnostic Hallmark
The Key Distinguishing Feature
HEMODILUTION
↓ Hct · ↓ Albumin
Mirror Syndrome
Anemia from fluid overload
HEMOCONCENTRATION
↑ Hct · ↑ Uric Acid
Severe Preeclampsia
Volume depletion
Always evaluate for fetal hydrops when maternal edema is atypical or does not fit classic preeclampsia.
Management
Management Framework
1. Confirm diagnosis: fetal hydrops + maternal edema triad
↓
2. Determine etiology of fetal hydrops (Rh, TTTS, Parvo B19, structural)
↓
3. Maternal stabilization — ICU-level hemodynamic monitoring
↓
Is the hydrops etiology reversible in utero?
YES →
Fetal therapy
(IUT, fetoscopic laser, cardiac Rx)
NO →
Delivery or pregnancy termination
regardless of gestational age
Fetal Therapy
In-Utero Fetal Therapy Options
🩸
Intrauterine Transfusion
Parvovirus B19
Rh alloimmunization
🔬
Fetoscopic Laser Ablation
Twin-Twin Transfusion Syndrome (TTTS)
💊
Fetal Cardiac Therapy
Arrhythmia-driven hydrops
Transplacental antiarrhythmics
Successful fetal therapy → reliable resolution of maternal symptoms
Delivery Indications
When to Deliver
- Maternal pulmonary edema or cardiac decompensation
- Refractory hypertension unresponsive to therapy
- Non-survivable fetal anomaly — lethal condition
- Failed or ineligible for in-utero fetal therapy
- Delivery reliably resolves maternal fluid retention over days
Maternal safety strictly dictates the timeline for intervention — regardless of gestational age.
Patient Counseling
Counseling the Patient
What is this?
Your body is retaining fluid as a direct response to your baby's severely swollen condition and placenta.
Why does it matter?
The fluid overload threatens your heart and lungs. Your safety is the absolute priority.
What is the prognosis?
Fetal mortality is high — up to 67%. Survival depends entirely on whether the cause of fetal swelling can be reversed.
What happens next?
Treatment of the fetus, or delivery, will halt the disease process. Your symptoms will resolve over several days.
Maternal Outcomes
Maternal Prognosis
✅
After Delivery or Hydrops Resolution
Maternal symptoms reliably regress. Edema, hypertension, and hemodilution normalize over days.
⚠️
Acute Risks
Pulmonary edema, cardiac decompensation — requires ICU-level or high-acuity obstetric monitoring.
🏥
Level of Care
High-acuity obstetric unit or ICU. Parallel maternal and fetal assessment required.
📉
Maternal Mortality
Rare with prompt recognition and management. Delay in diagnosis increases risk.
Summary
Clinical Takeaways
- 1Mirror syndrome = maternal + fetal + placental edema triad — a life-threatening obstetric emergency
- 2Distinguish from preeclampsia: hemodilution (↓ Hct, ↓ albumin) is the diagnostic key
- 3Fetal mortality up to 67.2% — etiology of hydrops drives prognosis and management
- 4Successful fetal therapy can resolve maternal disease — always evaluate reversibility
- 5Delivery is definitive treatment; maternal symptoms reliably resolve after intervention
References
Key References
- Ballantyne JW. The Bradshaw Lecture on Ante-Partum Haemorrhage. 1892. (First description of Mirror syndrome)
- Braun T, et al. "Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome." J Perinat Med. 2010. (PMC5889608)
- Espinoza J, et al. "Mirror syndrome and severe fetal hydrops." Ultrasound Obstet Gynecol. 2006. (PMC4659014)
- Llurba E, et al. "Mirror syndrome: clinical and pathophysiological review." J Matern Fetal Neonatal Med. 2020. (PMC10719984)
- Tan YL, et al. "Mirror syndrome complicating twin-to-twin transfusion syndrome." J Matern Fetal Neonatal Med. 2020.
- SMFM Consult Series: Fetal Hydrops — Society for Maternal-Fetal Medicine.
- Children's Hospital Boston. Mirror Syndrome Clinical Overview. childrenshospital.org
- DoctorsWhoCode.blog | OpenMFM.org